Back to mobile site

Wells Fargo on Eli Lilly (LLY): 'Compounders Strike Again, but We See Little Risk to Near-Term Growth'

February 5, 2026 10:10 AM EST Send to a Friend
Wells Fargo analyst Mohit Bansal reiterated an Overweight rating and $1,280.00 price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login